Grey Wolf Therapeutics Limited is a clinical‑stage biotechnology company that develops antigen‑modul Sign up to read more
No filings found for this company.
| Shareholder | Share class | Shares | Holding |
|---|---|---|---|
| BIODISCOVERY 5 FPCI REPRESENTED BY ITS MANAGEMENT COMPANY ANDERA PARTNERSCORP | SERIES A1 PREFERRED, SERIES A2 PREFERRED, SERIES A3 PREFERRED, SERIES B PREFERRED, SERIES B2 PREFERRED | 6,370,271 | 21.1% |
| 8888888888888888888888 | 8888888888 | 8888888 | 88888 |
| 88888888888888888888888888 | 8888888888 | 8888888 | 88888 |
| 888888888888888888 | 8888888888 | 888888 | 8888 |
| 8888888888888 |
Companies with the most similar business descriptions.
Capital raised per employee divides the equity GREY WOLF THERAPEUTICS LIMITED raised in the last six months by the headcount in its most recent filed accounts. It is a rough read on how capital-intensive the business is: a high figure means the company is raising a lot relative to the number of people it employs, which is typical of hardware, biotech and other research-heavy businesses. Headcount comes from annual accounts and so lags the funding date, often by a year or more.
A share class is a category of shares carrying its own rights over voting, dividends and what happens to the money if the company is sold or wound up. UK companies typically issue Ordinary shares to founders and employees, then create a new Preferred class at each funding round, giving investors priority on proceeds ahead of the Ordinary holders. GREY WOLF THERAPEUTICS LIMITED has 8 distinct classes on file at Companies House; the rights attached to each are reproduced below as filed.
THE FOLLOWING RIGHTS ATTACH TO THE GROWTH SHARES; (A) THE RIGHT TO VOTE (B) THE RIGHT, AS RESPECTS TO DIVIDENDS, TO PARTICIPATE IN A DISTRIBUTION; AND (C) THE RIGHT AS RESPECTS TO CAPITAL, TO PARTICIPATE IN A DISTRIBUTION (INCLUDING ON A WINDING UP). THE GROWTH SHARES ARE NON-REDEEMABLE.
THE FOLLOWING RIGHTS ATTACH TO THE GROWTH SHARES; (A) THE RIGHT TO VOTE (B) THE RIGHT, AS RESPECTS TO DIVIDENDS, TO PARTICIPATE IN A DISTRIBUTION; AND (C) THE RIGHT AS RESPECTS TO CAPITAL, TO PARTICIPATE IN A DISTRIBUTION (INCLUDING ON A WINDING UP). THE GROWTH SHARES ARE NON-REDEEMABLE.
THE FOLLOWING RIGHTS ATTACH TO THE ORDINARY SHARES; (A) THE RIGHT VOTE; (B) THE RIGHT, AS RESPECTS DIVIDENDS, TO PARTICIPATE IN A DISTRIBUTION IN ACCORDANCE WITH ARTICLE 5 OF THE COMPANY'S ARTICLES OF ASSOCIATION (THE ARTICLES); AND (C) THE RIGHT, AS RESPECTS CAPITAL, TO PARTICIPATE IN A DISTRIBUTION (INCLUDING ON A WINDING UP) IN ACCORDANCE WITH ARTICLE 6 OF THE ARTICLES. THE ORDINARY SHARES ARE NON-REDEEMABLE.
These are the directors and secretaries who have left GREY WOLF THERAPEUTICS LIMITED. A resignation is filed with Companies House on form TM01 and the date below is the date the officer's appointment ended, not the date it was filed. Departures matter for reading a company's history: a founder leaving shortly after a funding round, or several directors resigning at once, is often the visible trace of a change of control or a restructure.
| 88888888 |
| 888888 |
| 8888 |
| 8888888888888 | 88888888 | 888888 | 8888 |
52 more shareholders on file , sign up free to see.
THE FOLLOWING RIGHTS ATTACH TO THE SERIES AL PREFERRED SHARES; (A) THE RIGHT VOTE; (B) THE RIGHT, AS RESPECTS DIVIDENDS, TO PARTICIPATE IN A DISTRIBUTION IN ACCORDANCE WITH ARTICLE 5 OF THE COMPANY'S ARTICLES OF ASSOCIATION (THE ARTICLES); AND (C) THE RIGHT, AS RESPECTS CAPITAL, TO PARTICIPATE IN A DISTRIBUTION (INCLUDING ON A WINDING UP) IN ACCORDANCE WITH ARTICLE 6 OF THE ARTICLES. THE SERIES AL PREFERRED SHARES ARE NON-REDEEMABLE.
THE FOLLOWING RIGHTS ATTACH TO THE SERIES A2 PREFERRED SHARES; (A) THE RIGHT VOTE; (B) THE RIGHT, AS RESPECTS DIVIDENDS, TO PARTICIPATE IN A DISTRIBUTION IN ACCORDANCE WITH ARTICLE 5 OF THE COMPANY'S ARTICLES OF ASSOCIATION (THE ARTICLES); AND (C) THE RIGHT, AS RESPECTS CAPITAL, TO PARTICIPATE IN A DISTRIBUTION (INCLUDING ON A WINDING UP) IN ACCORDANCE WITH ARTICLE 6 OF THE ARTICLES. THE SERIES A2 PREFERRED SHARES ARE NON-REDEEMABLE.
THE FOLLOWING RIGHTS ATTACH TO THE SERIES A3 PREFERRED SHARES; (A) THE RIGHT VOTE; (B) THE RIGHT, AS RESPECTS DIVIDENDS, TO PARTICIPATE IN A DISTRIBUTION IN ACCORDANCE WITH ARTICLE 5 OF THE COMPANY'S ARTICLES OF ASSOCIATION (THE ARTICLES); AND (C) THE RIGHT, AS RESPECTS CAPITAL, TO PARTICIPATE IN A DISTRIBUTION (INCLUDING ON A WINDING UP) IN ACCORDANCE WITH ARTICLE 6 OF THE ARTICLES. THE SERIES A3 PREFERRED SHARES ARE NON-REDEEMABLE.
THE FOLLOWING RIGHTS ATTACH TO THE SERIES B PREFERRED SHARES; (A) THE RIGHT VOTE; (B) THE RIGHT, AS RESPECTS DIVIDENDS, TO PARTICIPATE IN A DISTRIBUTION IN ACCORDANCE WITH ARTICLE 5 OF THE COMPANY'S ARTICLES OF ASSOCIATION (THE ARTICLES); AND (C) THE RIGHT, AS RESPECTS CAPITAL, TO PARTICIPATE IN A
THE FOLLOWING RIGHTS ATTACH TO THE SERIES B2 PREFERRED SHARES; (A) THE RIGHT VOTE; (B) THE RIGHT, AS RESPECTS DIVIDENDS, TO PARTICIPATE IN A DISTRIBUTION; AND (C) THE RIGHT, AS RESPECTS CAPITAL, TO PARTICIPATE IN A DISTRIBUTION (INCLUDING ON A WINDING UP). THE SERIES B2 PREFERRED SHARES ARE NON-REDEEMABLE.